|
Mar 15
|
Down 93%, Is It Finally Time to Buy Moderna?
|
|
Mar 14
|
Markets Rebound, But Short Sellers Are Circling--Is This Rally Built to Last?
|
|
Mar 13
|
Citi says SMid biotechs alternative to large caps as it starts coverage
|
|
Mar 12
|
Moderna (NasdaqGS:MRNA) Up 11% Despite Patent Lawsuit Challenges
|
|
Mar 12
|
3 Reasons MRNA is Risky and 1 Stock to Buy Instead
|
|
Mar 11
|
Winners And Losers Of Q4: Myriad Genetics (NASDAQ:MYGN) Vs The Rest Of The Therapeutics Stocks
|
|
Feb 22
|
Why Moderna Inc. (MRNA) Surged On Friday?
|
|
Feb 21
|
Moderna and Other Vaccine Stocks Climb Amid Concerns About Coronavirus Study in China
|
|
Feb 20
|
Will Moderna Stock Drop to $25? 1 Wall Street Analyst Thinks So.
|
|
Feb 19
|
Biotech Stock Roundup: MRNA's Q4 Results, GILD's Update & Other News
|
|
Feb 19
|
Bausch and Lomb's dealmaking CEO Brent Saunders: No deal for company is imminent
|
|
Feb 19
|
Why Moderna (MRNA) Went Up on Tuesday?
|
|
Feb 19
|
Challenges mount for vaccine makers
|
|
Feb 18
|
Why Moderna (MRNA) Stock Is Up Today
|
|
Feb 18
|
Moderna Downgraded by Barclays as Policy Risks and Weak Revenue Weigh on Outlook
|
|
Feb 18
|
Moderna has limited upside: Barclays
|
|
Feb 18
|
Should You Buy, Hold or Sell Moderna Stock Post Q4 Earnings Release?
|
|
Feb 18
|
Is Moderna Stock A Buy As Its CEO Fends Off RFK Jr. Concerns?
|
|
Feb 18
|
First Cows, Now Cats. Is Bird Flu Coming for Humans Next?
|
|
Feb 17
|
Moderna reports decline in Q4 2024 revenue
|